Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Sep;14(9):3108-3110.
doi: 10.21037/jtd-22-1099.

Resect a little, resect more, irradiate or ablate-what is the best approach?

Conor M Maxwell  1 , Hiran C Fernando  2
Affiliations
Editorial

Resect a little, resect more, irradiate or ablate-what is the best approach?

Conor M Maxwell et al. J Thorac Dis. 2022 Sep.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-22-1099/coif). HCF serves as an unpaid editorial board member of Journal of Thoracic Disease. HCF was a member of the Steering committee of Merck for a study of neoadjuvant immunotherapy (not related to current topic) in the past 36 months. The other author has no conflicts of interest to declare.

Comment on

References

    1. Detterbeck FC, Blasberg JD, Woodard GA, et al. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 1: a guide to decision-making. J Thorac Dis 2022;14:2340-56. 10.21037/jtd-21-1823 - DOI - PMC - PubMed
    1. Detterbeck FC, Mase VJ, Jr, Li AX, et al. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 2: systematic review of evidence regarding resection extent in generally healthy patients. J Thorac Dis 2022;14:2357-86. 10.21037/jtd-21-1824 - DOI - PMC - PubMed
    1. Bade BC, Blasberg JD, Mase VJ, Jr, et al. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 3: systematic review of evidence regarding surgery in compromised patients or specific tumors. J Thorac Dis 2022;14:2387-411. 10.21037/jtd-21-1825 - DOI - PMC - PubMed
    1. Park HS, Detterbeck FC, Madoff DC, et al. A guide for managing patients with stage I NSCLC: deciding between lobectomy, segmentectomy, wedge, SBRT and ablation-part 4: systematic review of evidence involving SBRT and ablation. J Thorac Dis 2022;14:2412-36. 10.21037/jtd-21-1826 - DOI - PMC - PubMed
    1. Altorki NK, Wang X, Wigle D, et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med 2018;6:915-24. 10.1016/S2213-2600(18)30411-9 - DOI - PMC - PubMed